HZ08 inhibits the multi-drug resistance on multiple sites as the substrate of p-glycoprotein

European Journal of Pharmacology

Volumn 712, Issue 1-3, 2013, Pages 53-59

  Feng, Yidong ^a   Hu, Yahui ^a   Cen, Juan ^a   Darshika, Kodithuwakku Nandani ^a   Fang, Weirong ^a   Li, Yunman ^a   Huang, Wenlong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Drug interaction; HZ08; Multi drug resistance; P glycoprotein

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; HZ 08; HZ08; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; RHODAMINE 123; SMALL INTERFERING RNA; TETRAHYDROISOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; BINDING SITE; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG STRUCTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

BINDING SITES; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; HUMANS; INTRACELLULAR SPACE; ISOQUINOLINES; K562 CELLS; P-GLYCOPROTEIN; RHODAMINE 123; VERAPAMIL;

EID: 84878230886     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.04.028     Document Type: Article

References (29)

1. S. Ayesh, Y.M. Shao, and W.D. Stein Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein Biochim. Biophys. Acta 1316 1996 8 18 (Pubitemid 26174919)
2. M. Ballent, A. Lifschitz, G. Virkel, J. Sallovitz, and C. Lanusse Modulation of the P-glycoprotein-mediated intestinal secretion of ivermectin: in vitro and in vivo assessments Drug Metab. Dispos. 34 2006 457 463 (Pubitemid 43290904)
3. H.J. Broxterman, K.J. Gotink, and H.M. Verheul Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib Drug Resist. Updat. 12 2009 114 126
4. R.A. Darby, R. Callaghan, and R.M. McMahon P-glycoprotein inhibition: the past, the present and the future Curr. Drug Metab. 12 2011 722 731
5. R. Ding, J. Shi, K. Pabon, and K.W. Scotto Xanthines down-regulate the drug transporter ABCG2 and reverse multidrug resistance Mol. Pharmacol. 81 2012 328 337
6. M. Filipits, V. Haddad, K. Schmid, A. Huynh, A. Dunant, F. Andre, E. Brambilla, R. Stahel, J.P. Pignon, J.C. Soria, H.H. Popper, T. Le Chevalier, and R. Pirker Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: international adjuvant lung cancer trial biologic program Clin. Cancer Res. 13 2007 3892 3898 (Pubitemid 47037596)
7. S. Forster, A.E. Thumser, S.R. Hood, and N. Plant Characterization of rhodamine-123 as a tracer dye for use in in vitro drug transport assays PloS One 7 2012 e33253
8. R. Krishna, and L.D. Mayer Modulation of P-glycoprotein (PGP) mediated multidrug resistance (MDR) using chemosensitizers: recent advances in the design of selective MDR modulators Curr. Med. Chem. Anticancer Agents 1 2001 163 174
9. H. Lage MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance Curr. Drug Targets 7 2006 813 821
10. H. Lage An overview of cancer multidrug resistance: a still unsolved problem Cell. Mol. Life Sci. 65 2008 3145 3167
11. I.V. Lebedeva, P. Pande, and W.F. Patton Sensitive and specific fluorescent probes for functional analysis of the three major types of mammalian ABC transporters PloS One 6 2011 e22429
12. I. Leitner, J. Nemeth, T. Feurstein, A. Abrahim, P. Matzneller, H. Lagler, T. Erker, O. Langer, and M. Zeitlinger The third-generation P-glycoprotein inhibitor tariquidar may overcome bacterial multidrug resistance by increasing intracellular drug concentration J. Antimicrob. Chemother. 66 2011 834 839
13. T.W. Loo, and D.M. Clarke Location of the rhodamine-binding site in the human multidrug resistance P-glycoprotein J. Biol. Chem. 277 2002 44332 44338 (Pubitemid 36157868)
14. M.R. Lugo, and F.J. Sharom Interaction of LDS-751 with P-glycoprotein and mapping of the location of the R drug binding site Biochemistry 44 2005 643 655 (Pubitemid 40105495)
15. C. Martin, G. Berridge, C.F. Higgins, P. Mistry, P. Charlton, and R. Callaghan Communication between multiple drug binding sites on P-glycoprotein Mol. Pharmacol. 58 2000 624 632
16. K. Mehta, and Z.H. Siddik Drug Resistance in Cancer Cells 2009 Springer New York, NY
17. S. Nobili, I. Landini, B. Giglioni, and E. Mini Pharmacological strategies for overcoming multidrug resistance Curr. Drug Targets 7 2006 861 879
18. A. Palmeira, E. Sousa, M.H. Vasconcelos, and M.M. Pinto Three decades of P-gp inhibitors: skimming through several generations and scaffolds Curr. Med. Chem. 19 2012 1946 2025
19. S.J. Park, K. Bijangi-Vishehsaraei, and A.R. Safa Selective TRAIL-triggered apoptosis due to overexpression of TRAIL death receptor 5 (DR5) in P-glycoprotein-bearing multidrug resistant CEM/VBL1000 human leukemia cells Int. J. Biochem. Mol. Biol. 1 2010 90 100
20. Z. Peng, Z. Xiao, Y. Wang, P. Liu, Y. Cai, S. Lu, W. Feng, and Z.C. Han Reversal of P-glycoprotein-mediated multidrug resistance with small interference RNA (siRNA) in leukemia cells Cancer Gene Ther. 11 2004 707 712 (Pubitemid 39488468)
21. J. Rautio, J.E. Humphreys, L.O. Webster, A. Balakrishnan, J.P. Keogh, J.R. Kunta, C.J. Serabjit-Singh, and J.W. Polli In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates Drug Metab. Dispos. 34 2006 786 792
22. Y.M. Shao, S. Ayesh, and W.D. Stein Mutually co-operative interactions between modulators of P-glycoprotein Biochim. Biophys. Acta 1360 1997 30 38 (Pubitemid 27083657)
23. A.B. Shapiro, and V. Ling Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities Eur. J. Biochem./FEBS 250 1997 130 137 (Pubitemid 27504592)
24. A.B. Shapiro, and V. Ling The mechanism of ATP-dependent multidrug transport by P-glycoprotein Acta Physiol. Scand. Suppl. 643 1998 227 234 (Pubitemid 28439422)
25. R. Shi, W. Li, X. Zhang, Y. Zhang, H. Peng, Y. Xie, D. Fan, R. Liu, X. Liu, and D. Xiong A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cells Eur. J. Pharmacol. 669 2011 38 44
26. A.A. Shtil P-glycoprotein as a therapeutic target: good news Leukemia 16 2002 2169 2170
27. F. Yan, W.R. Fang, J. Cen, T.J. Hang, and Y.M. Li Effect of HZ08, a novel modulator of tumor multidrug-resistance, on adriamycin pharmacokinetics in rats Chin. J. New Drugs 39 2008 447 452
28. F. Yan, Y. Jiang, Y.M. Li, X. Zhen, J. Cen, and W.R. Fang Reversal of P-glycoprotein and multidrug resistance-associated protein 1 mediated multidrug resistance in cancer cells by HZ08 Isomers, tetrataisohydroquinolin derivatives Biol. Pharmaceut. Bull. 31 2008 1258 1264 (Pubitemid 351871172)
29. K. Yang, J. Wu, and X. Li Recent advances in the research of P-glycoprotein inhibitors Biosci. Trends 2 2008 137 146